Value-Based Insurance Design: By abandoning the archaic principle that all services must cost the same for all patients, we can move to a high-value health system.

ME Chernew, AB Rosen, AM Fendrick - Health Affairs, 2007 - healthaffairs.org
When everyone is required to pay the same out-of-pocket amount for health care services
whose benefits depend on patient characteristics, there is enormous potential for both under …

Influencers of generic drug utilization: a systematic review

JN Howard, I Harris, G Frank, Z Kiptanui, J Qian… - Research in Social and …, 2018 - Elsevier
Introduction With an increase in prescription drug spending and rising drug costs there is a
need to encourage the use of generic prescription drugs. However, maximizing generic drug …

Comparing generic drug markets in Europe and the United States: prices, volumes, and spending

OJ Wouters, PG Kanavos, M McKee - The Milbank Quarterly, 2017 - Wiley Online Library
Policy Points: Our study indicates that there are opportunities for cost savings in generic
drug markets in Europe and the United States. Regulators should make it easier for generic …

Demand for health insurance

TG McGuire - Handbook of health economics, 2011 - Elsevier
This chapter reviews topics related to the demand for health insurance, including the
question of how choice of health insurance should be structured for consumers. After the first …

Impact of multitiered copayments on the use and cost of prescription drugs among Medicare beneficiaries

BH Gilman, J Kautter - Health services research, 2008 - Wiley Online Library
Objectives. To assess the impact of multitiered copayments on the cost and use of
prescription drugs among Medicare beneficiaries. Data Sources. Marketscan 2002 Medicare …

In Medicare Part D plans, low or zero copays and other features to encourage the use of generic statins work, could save billions

JF Hoadley, K Merrell, E Hargrave, L Summer - Health affairs, 2012 - healthaffairs.org
The private health plans that administer the Medicare drug benefit use various tools to
encourage the use of generic drugs in order to lower total drug spending. Higher generic …

Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform

OJ Woutersa, PG Kanavosa - Bulletin of the World Health …, 2015 - SciELO Public Health
Objective To review the pharmaceutical sector in Cyprus in terms of the availability and
affordability of medicines and to explore pharmaceutical policy options for the national …

Patient-centered outcomes of a value-based insurance design program for patients with diabetes

DJ Elliott, EJ Robinson, KB Anthony… - Population health …, 2013 - liebertpub.com
Value-based insurance design (VBID) initiatives have been associated with modest
improvements in adherence based on evaluations of administrative claims data. The …

Impact of cost sharing on prescription drugs used by Medicare beneficiaries

AM Goedken, JM Urmie, KB Farris… - Research in Social and …, 2010 - Elsevier
BACKGROUND: Incentive-based prescription drug cost sharing can encourage seniors to
use generic medications. Little information exists about prescription drug cost sharing and …

Impact of pharmacy benefit design on prescription drug utilization: a fixed effects analysis of plan sponsor data

MC Roebuck, JN Liberman - Health Services Research, 2009 - Wiley Online Library
Objective. To study the impact of various elements of pharmacy benefit design on both the
absolute and relative utilization of generics, brands, retail pharmacy, and mail service. Data …